Cargando…
Clinical considerations and key issues in the management of patients with Erdheim-Chester Disease: a seven case series
BACKGROUND: Erdheim-Chester Disease (ECD), a non Langerhans’ cell histiocytosis of orphan nature and propensity for multi-systemic presentations, comprises an intricate medical challenge in terms of diagnosis, treatment and complication management. OBJECTIVES: The objectives are to report the clinic...
Autores principales: | Mazor, Roei D, Manevich-Mazor, Mirra, Kesler, Anat, Aizenstein, Orna, Eshed, Iris, Jaffe, Ronald, Pessach, Yakov, Goldberg, Ilan, Sprecher, Eli, Yaish, Iris, Gural, Alexander, Ganzel, Chezi, Shoenfeld, Yehuda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4248471/ https://www.ncbi.nlm.nih.gov/pubmed/25434739 http://dx.doi.org/10.1186/s12916-014-0221-3 |
Ejemplares similares
-
Erdheim-Chester Disease: a comprehensive review of the literature
por: Mazor, Roei D, et al.
Publicado: (2013) -
The Contribution of MicroRNAs to the Inflammatory and Neoplastic Characteristics of Erdheim–Chester Disease
por: Weissman, Ran, et al.
Publicado: (2020) -
PB2208: CLUSTER ANALYSIS UNVEILS THE CLINICAL SPECTRUM OF ERDHEIM-CHESTER DISEASE
por: Tesi, Michelangelo, et al.
Publicado: (2023) -
Dual BRAF/MEK blockade restores CNS responses in BRAF-mutant Erdheim–Chester disease patients following BRAF inhibitor monotherapy
por: Mazor, Roei D, et al.
Publicado: (2020) -
Erdheim-Chester Disease
por: Yamamoto, Shinya, et al.
Publicado: (2019)